CN110684769B - Ostrea gigas EF-1 alpha promoter, recombinant vector and application thereof - Google Patents
Ostrea gigas EF-1 alpha promoter, recombinant vector and application thereof Download PDFInfo
- Publication number
- CN110684769B CN110684769B CN201910975861.4A CN201910975861A CN110684769B CN 110684769 B CN110684769 B CN 110684769B CN 201910975861 A CN201910975861 A CN 201910975861A CN 110684769 B CN110684769 B CN 110684769B
- Authority
- CN
- China
- Prior art keywords
- crassostrea gigas
- promoter
- alpha
- gene
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000548230 Crassostrea angulata Species 0.000 title claims abstract description 51
- 239000013598 vector Substances 0.000 title abstract description 16
- 230000014509 gene expression Effects 0.000 claims abstract description 15
- 235000013601 eggs Nutrition 0.000 claims abstract description 13
- 210000001161 mammalian embryo Anatomy 0.000 claims abstract description 6
- 101150087698 alpha gene Proteins 0.000 claims abstract description 5
- 239000012634 fragment Substances 0.000 claims abstract description 5
- 239000013612 plasmid Substances 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 239000013604 expression vector Substances 0.000 claims description 11
- 238000003259 recombinant expression Methods 0.000 claims description 11
- 238000000520 microinjection Methods 0.000 claims description 9
- 238000011144 upstream manufacturing Methods 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 6
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 6
- 238000001976 enzyme digestion Methods 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 238000012163 sequencing technique Methods 0.000 claims description 6
- 241000237502 Ostreidae Species 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 235000020636 oyster Nutrition 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 4
- 239000012498 ultrapure water Substances 0.000 claims description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- 235000008708 Morus alba Nutrition 0.000 claims description 3
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 3
- 210000002459 blastocyst Anatomy 0.000 claims description 3
- 238000009395 breeding Methods 0.000 claims description 3
- 230000001488 breeding effect Effects 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 3
- 238000012257 pre-denaturation Methods 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 240000000249 Morus alba Species 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 108700039887 Essential Genes Proteins 0.000 abstract description 10
- 108091033409 CRISPR Proteins 0.000 abstract description 7
- 210000002257 embryonic structure Anatomy 0.000 abstract description 6
- 238000011161 development Methods 0.000 abstract description 4
- 238000010362 genome editing Methods 0.000 abstract description 4
- 238000010354 CRISPR gene editing Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 108700008625 Reporter Genes Proteins 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 19
- 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 11
- 239000000047 product Substances 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/70—Invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/103—Plasmid DNA for invertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a crassostrea gigas EF-1 alpha promoter, a recombinant vector and application thereof. The EF-1 alpha promoter provided by the invention is a high-expression housekeeping gene promoter, and can be expressed in the early development stage of the crassostrea gigas embryo. The concrete expression is as follows: designing a specific primer, amplifying an EF-1 alpha gene promoter fragment of the crassostrea gigas, inserting the promoter fragment into a vector containing a GFP reporter gene by utilizing In-Fusion connection, and introducing the recombinant vector into fertilized eggs of the crassostrea gigas to efficiently drive the GFP reporter gene to express In the embryos and larvae of the crassostrea gigas. The invention obtains the general efficient promoter sequence of the crassostrea gigas and provides an important technical basis for promoting the development of the crassostrea gigas CRISPR/Cas9 targeted gene editing technology.
Description
Technical Field
The invention relates to the fields of genetic engineering and molecular biology, and particularly relates to an EF-1 alpha promoter of crassostrea gigas, a recombinant vector and application thereof.
Background
The crassostrea gigas has important economic value as a marine shellfish distributed worldwide. In recent years, genetic breeding work of crassostrea gigas is greatly advanced in China, new species of crassostrea gigas, such as 'Hailao No. 1' and 'Hailao No. 2', are successively cultured, and the adopted method is mainly the traditional artificial selective breeding. In recent years, the application of the CRISPR/Cas9 targeted gene editing technology in genetic improvement and variety breeding of animals and plants is receiving wide attention. By using a method of introducing Cas9 protein + sgRNA into fertilized eggs through microinjection, efficient and accurate target gene editing can be realized on crassostrea gigas. However, this method is not suitable for mass treatment of fertilized eggs, and the method of introducing plasmid DNA containing CRISPR/Cas9 system into fertilized eggs by electrotransfection or chemical transfection has the advantages of high throughput and low cost. However, the promoter sequences contained in the above plasmid DNAs are derived from viruses or model animals in many cases, and are not completely suitable for use in crassostrea gigas, and promoters capable of efficiently and stably driving the expression of foreign genes are still lacking in the studies of the gene functions of shellfish.
The promoter is a non-coding DNA sequence located upstream of the 5' end of the transcribed gene and capable of correctly and efficiently initiating transcription, and as a cis-acting element in the transcription process, it occupies a very important position in the regulation of gene expression. The promoter sequence mainly comprises a core promoter region and an upstream regulatory region. The core promoter region functions to recruit transcription factors and transcription enzymes to the promoter core region, recognize the transcription initiation site, and then the transcription enzymes perform functions, and the upstream regulatory region sequence has a stimulating effect on the transcription regulation process, and can control the transcription efficiency by combining with the corresponding transcription factor. The promoter acts like a "switch", and the core promoter element, upstream regulatory element and response element, etc. act together to determine the activity of the gene. The promoter elements and positions vary from gene to gene, and different combinations and sequence variations of these elements constitute a vast number of diverse promoters. Obviously, the development of a suitable promoter is a key link for achieving a suitable transcription efficiency of the target gene.
The high-efficiency promoter can promote the high-level expression of exogenous genes, and the housekeeping gene promoter of a certain species is usually required to obtain the constitutive expression of target genomes in the species. Housekeeping genes are an indispensable class of genes for maintaining minimal cell function, and are expressed in all cell types. Housekeeping gene expression levels are less influenced by environmental factors, are consistently and stably expressed in most, or almost all, tissues during various growth stages of an individual, and are only influenced by promoter sequences or the interaction of promoters with RNA polymerase, and are not regulated by other mechanisms. The number of housekeeping genes in organisms is large, a plurality of choices are provided for developing constitutive promoters, and at present, the efficient promoter suitable for crassostrea gigas is still not successfully developed.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide the crassostrea gigas EF-1 alpha promoter, a recombinant vector and application thereof.
In order to achieve the purpose, the invention adopts the following specific technical scheme:
an EF-1 alpha promoter of crassostrea gigas has a sequence shown in SEQ ID NO. 1.
The specific positions of the crassostrea gigas EF-1 alpha are as follows: the candidate promoter region was flanked by approximately 3500bp of the ATG front including the first exon and the first intron.
A recombinant expression vector comprising a nucleotide fragment of which the sequence is SEQ ID NO. 1.
The construction method of the recombinant expression vector is characterized by comprising the following specific steps of:
1) designing a Pair of specific amplification primers of an EF-1 alpha gene upstream promoter of the crassostrea gigas according to a crassostrea gigas genome sequence, and adding plasmid homologous ends, wherein the sequences are shown as SEQ ID NO. 2 and SEQ ID NO. 3;
2) taking the genomic DNA of the crassostrea gigas as a template, carrying out PCR amplification, and recovering a product;
3) digesting the plasmid and recovering the product;
4) carrying out In-Fusion connection on the enzyme digestion linearized plasmid and the recovered PCR product In the step 2), introducing the connection product into escherichia coli competent cells, carrying out plate screening, and selecting monoclonal shake bacteria for culture;
5) extracting bacteria liquid plasmids, carrying out enzyme digestion, selecting plasmids which accord with expectation according to the enzyme digestion result, sequencing, and naming the plasmids with correct sequencing as pEGFP-CgEF-1 alpha, namely the recombinant expression vector.
Further, the PCR system in step 2) is: 5x Phusion HF Buffer, 10. mu.l; 2.5mM dNTPs, 4. mu.l; 2.5. mu.l of upstream primer (10 uM); 2.5. mu.l of downstream primer (10 uM); 1. mu.l of template DNA (100 ng/. mu.l); phusion High-Fidelity DNA Polymerase 0.5. mu.l; 29.5. mu.l of ultrapure water. The amplification procedure was: pre-denaturation at 98 ℃ for 30 s; denaturation at 98 ℃ for 10s, annealing at 64 ℃ for 30s, extension at 72 ℃ for 1min for 20s, and 35 cycles; extension at 72 ℃ for 10 min.
Further, the enzyme cutting system in the steps 3) and 5) is as follows: 10 × CutSmart Buffer 5 μ l, plasmid DNA (150 ng/. mu.l) 6 μ l, BamHI enzyme (20U/. mu.l) 0.5 μ l, ultra pure water 37.5 μ l. The reaction program was 37 ℃ for 2 h.
Further, the In-Fusion linker In step 4) is: 5 XIn-Fusion HD Enzyme Premix 2. mu.l, linearized pEGFP-1 plasmid DNA (43 ng/. mu.l) 1.5. mu.l, and recovered product (16 ng/. mu.l) 6.5. mu.l. The reaction program is 50 ℃ for 15 min.
Further, in the step 1), plasmid pEGFP-1 is selected.
The specific application method of the recombinant expression vector is characterized in that the recombinant expression vector and phenol red mixture are introduced into fertilized eggs of crassostrea gigas by a microinjection method, and are continuously observed under a fluorescence microscope, so that green fluorescence can be observed in various cells of mulberries, blastocysts, gastral embryos, trochophores and D-shaped larvae, namely EGFP gene expression.
Further, the final concentration of the microinjected recombinant vector was 200 ng/. mu.l.
The crassostrea gigas EF-1 alpha promoter is applied to crassostrea gigas gene breeding.
The invention has the advantages and beneficial effects that:
the invention successfully develops the Elongation factor-1 alpha (EF-1 alpha) gene promoter sequence from a plurality of promoter sequences of the housekeeping genes of the crassostrea gigas, and the EF-1 alpha promoter provided by the invention is a high-expression housekeeping gene promoter and can be expressed at the early development stage of the crassostrea gigas embryo. The invention drives the constitutive expression of exogenous genes in the early embryo of the crassostrea gigas, further perfects the gene editing technology of the crassostrea gigas and provides a technical basis for developing the research on the gene functions of the crassostrea gigas.
Drawings
FIG. 1 is a diagram of a recombinant vector drawn by using SnapGene software.
FIG. 2 is a graph showing the results of EGFP expression in early embryos and larvae of crassostrea gigas injected with recombinant vectors.
Detailed Description
The present invention will be described in further detail with reference to the accompanying drawings, in which the experimental methods without specific conditions being noted are all conventional experimental conditions. The examples are given for the purpose of better illustration of the invention and the invention is not limited to these examples.
Example 1:
and (3) screening the promoter fragment of the crassostrea gigas housekeeping gene.
1) Preliminarily selecting 6 crassostrea gigas housekeeping genes such as EF-1 alpha, ACT,18S rRNA, 28S rRNA, RL7 and the like according to published crassostrea gigas genome data, further screening the housekeeping genes with stable and high expression in the crassostrea gigas embryonic period by combining the existing transcription group data, and selecting the EF-1 alpha gene with the highest expression quantity for further analysis;
2) specifically, the transcription factor binding site in the first ATG front flanking sequence of the crassostrea gigas EF-1 alpha is analyzed, and finally, the flanking sequence of about 3500bp in front of the ATG including the first exon and the first intron is used as a candidate promoter region.
Example 2:
and (3) amplifying the EF-1 alpha promoter of the crassostrea gigas.
1) The genomic DNA of the crassostrea gigas is extracted by a phenol chloroform method, specific primers are designed according to the sequence of a candidate EF-1 alpha gene promoter region, and 16 basic groups of vector pEGFP-1 homologous ends are added to the upstream primer and the downstream primer respectively, as shown in Table 1.
TABLE 1 primer sequences for the amplification of oyster EF-1. alpha. Gene promoter
The 16 base homologous end of the vector pEGFP-1 is underlined.
2) PCR amplification was carried out using a Phusion High-Fidelity DNA Polymerase from Thermo Scientific as a template. The PCR system is shown in Table 2. The PCR reaction program is: pre-denaturation at 98 ℃ for 30 s; denaturation at 98 ℃ for 10s, annealing at 64 ℃ for 30s, extension at 72 ℃ for 1min for 20s, and 35 cycles; extension at 72 ℃ for 10 min.
TABLE 2 PCR reaction System for the amplification of oyster EF-1. alpha. Gene promoter
3) The PCR amplification product was separated by 1% agarose Gel electrophoresis to obtain a band of about 3500bp in size, which was then purified and recovered by Gel cutting using the GeneJET Gel Extraction Kit (K0692) from Thermo Scientific.
Example 3:
and (3) constructing a pEGFP-CgEF-1 alpha recombinant expression vector.
1) Plasmid pEGFP-1 was digested with the New England BioLabs restriction enzyme BamH I, as shown in Table 3. The reaction program was 37 ℃ for 2 h.
TABLE 3 BamH I digestion of plasmid pEGFP-1 reaction System
2) The linearized pEGFP-1 was recovered as a cut gel, and subjected to In-Fusion ligation with the PCR-recovered product (In-Fusion HD Cloning Kit, TaKaRa). The In-Fusion ligation system is shown In Table 4, and the reaction procedure is 50 ℃ for 15 min.
TABLE 4 In-Fusion ligation System
3) Taking out Escherichia coli DH5 alpha competent cell, storing at-80 deg.C, placing on ice, adding 10 μ l ligation product into 100 μ l competent cell, mixing, placing on ice for 30min, heat-shocking at 42 deg.C for 60-90s, and placing on ice for 2 min. Add 500. mu.l SOC medium and incubate at 37 ℃ for 1h at 150 rpm. Centrifuging at 3000rpm for 2-3min, sucking 450 μ l of supernatant, and suspending the bacterial suspension with the residual culture medium. The resuspended suspension was spread on LB plates containing kanamycin antibiotics and cultured for 16h at 37 ℃ in an inverted manner.
4) Single colonies were picked, cultured in 3ml LB broth containing kanamycin antibiotic for 16h, plasmids were extracted using the Endo-Free Plasmid Mini Kit I (D6948) from OMEGA Bio-tek, and digested with BamH I, selecting plasmids that cleaved two DNA bands of about 4100bp and about 3500 bp. The sequencing primers were CgEF-1. alpha.F and CgEF-1. alpha.R, and the plasmid with the correct sequencing was designated as pEGFP-CgEF-1. alpha (as shown in FIG. 1).
Example 4:
EGFP expression in crassostrea gigas embryos and larvae.
1) Preparing the extracted pEGFP-CgEF-1 alpha recombinant vector into an injection: recombinant vector 200 ng/. mu.l, phenol red 0.05%.
2) Selecting oysters with mature gonads, collecting sperms and ova by an anatomical method, carrying out artificial insemination, and collecting fertilized ova for microinjection.
3) Placing the fertilized eggs of the crassostrea gigas collected in the step 1) in the center of a polypropylene culture dish with the diameter of 60mm, dripping 1 drop of seawater, placing under an inverted microscope, and adjusting the fertilized eggs to the center of the visual field. Using a Microloader (eppendorf), 1. mu.l of the injection solution was aspirated and injected into the injection needle, which was connected to a nitrogen-pressurized quantitative microinjection system (WARNER, PLI-100A). The pressure of the suction needle is adjusted to be negative pressure by utilizing a pneumatic manual microinjection instrument, and one fertilized egg is sucked and fixed. Using a microinjection system, 0.1nL of the injection was injected into fertilized eggs of crassostrea gigas. After the injection, the injected eggs are discharged by adjusting the internal pressure of the holding needle to be positive pressure, the position of the holding needle is changed, and other fertilized eggs are held by the internal pressure of the holding needle, so that the injection is carried out one by one. And culturing the fertilized eggs in sterile seawater at 23-24 ℃.
4) After microinjection, embryos and larvae are observed under a fluorescence microscope every other hour, and the result shows that green fluorescence can be observed after microinjection is carried out for four hours, which indicates that the crassostrea gigas EF-1 alpha promoter can very early start EGFP gene expression. FIG. 2 shows embryos, trochophores and D-type larvae of the Mulberry stage, the blastocyst stage, the gastral stage and the gastral stage of the Ostreea gigas which emit green fluorescence under a fluorescence microscope.
As can be seen from FIG. 2, green fluorescence can be observed in various types of cells of the crassostrea gigas embryo and the larva, and the EGFP gene expression has no tissue specificity, so that the recombinant vector can drive the constitutive expression of the target gene in the early stage of the crassostrea gigas embryo and the larva.
Sequence listing
<110> China oceanic university
<120> crassostrea gigas EF-1 alpha promoter, recombinant vector and application thereof
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 3465
<212> DNA
<213> Pacific oyster (Crassostra gigas)
<400> 1
actatatgac ggactggaca acaggcttta tctgctttta aaaatttcga aatgatcgag 60
tgaatatcag ttttcggaaa tacatttcat atatgtacat ctaccaagca taatttcctc 120
tatttcttac ggaaacttat agttaattca tagctctata gaaacagcca gactgaaatc 180
tacacgccct atttatcgat tggtcgaaat ctacagcggc tgaaagtgac aggacagaaa 240
ttgacacgcc ctgtttatcg attggtctga acctacagcg actttagtaa aagcccggac 300
tgcacgaaat aatcatgacg atgccagact caaagtctca caagagacct ctaccatcgg 360
ctcatacatt cagagaggaa cgaacgacaa ctctgcatgg gagattgacg attttgctgt 420
ttcttttagc taacgtactt ttgtacatta acagtaattt agtgaatttt actaactttt 480
cataatcagt ttattaatta gttaaagata gatgttaata taaacaataa aatgctttct 540
ttgatggttc atgcgggtaa tgaagatagc gatcattgca ggaaaaatgt acataacccg 600
ctacgtattt ttccagcaat gtcgctacct tcatatcccg aatgaatcac caaagaaagc 660
attttattgt ttaaataaat gcaaactaaa catcaataaa tattttacaa agcgtgcaaa 720
aaaatagttt tttaagctca aaactgcatg taaaagcatt ggttaaacat gttaatcatt 780
ttgagtacta ttatagtatt gatatataca atattatata aatggtacac gaaaaaaatc 840
aacaaaaaga attcagcaag atataaaaac tatttaacgt ttctataata tagaattatt 900
tgtcagttgc aatcacataa ccggcttaca ggtacaggtt aaccttgcaa ctctgacttc 960
taaaaggaat ttaaatttac aagatgtagg tatagcaaac taactactag tatttaaata 1020
gattcctctt gcaaaaaatt gcttaaattt tctgaatttc ctgtgttcct acaaaaaata 1080
tagaaaactt acgatgtgtg atgaaagcat tgtgtagtga cggacttaaa aggcatttga 1140
taaacatatt gtgtattcag tattgcaatc tgattaaaat acagatctct acataagcgc 1200
acagcgcaga gagatcatct ctctgcgctg tgcgcttatg tagagatctg tataaaactt 1260
ttttttatta gattggttaa aattggtact attggtggga tctggatttc gcacttcgag 1320
gcggtggtaa agggccgaag aaaaaaatca tagtttatcg tatatcgcaa attacgccat 1380
gaaaattaac atactgtaca taccttcttg attcatattt aaatttcgaa tggttttatg 1440
ttatcaatga ggctagctta aacttacttt ttctataaat ttcaattcaa tataataaca 1500
cgtaaactgt cccaacacat gtacagatta aatactcgaa tgtataacaa gtaaatgagt 1560
agatttaaat aatggtcgtt ttttaaaagt atatatcaga aacacccggc cggtctatgt 1620
gcatacagct cttgtaatac aatacatatt ttaagtatat agttgtatga aaatacacat 1680
tattcaagtg atctttcatt gtccaatgaa agaaaaaacc cactgtactt tctcacatta 1740
atttacaaat tttgacaggt attatatatt ctttttaatc taagggcatc attttacatg 1800
ctttttcaca cgtggccctc cagagtggtt gtcatcaacg tacctttggg gtgaattaaa 1860
caacaaccat aaaacaaaca ttttagtgac taggacttat tcgataagct atttttatac 1920
tttgacgtat tttgacggtg tgcataaaaa caggaaataa tcttcaataa aattataaat 1980
aaagaaagat attaagataa catgtatgaa caaaaatcaa gataaacaat ccagaaattg 2040
aaaaacatac ttttgtatta tgagtaaggt atatatttat ttcaagctga aaaaagaaac 2100
atcacgtcag gcgcccattc ttaggatgaa ggtgatgaat tataagatta cttacacttt 2160
gcaagaaaaa tatgtttcaa aaataacttt atatcatgta ttattaacag tatcgaataa 2220
aacagagagt ttttgaaaga atagtattgt atttttgcta aagtatcttt tttgtctcac 2280
ttaaccattt tctggttact agtcatatcg ggtaatcctt aaccgtgacg ttatcaacac 2340
gtgacaatcc tctctctttc ctttttgctg tggcgaactc tgagagtaag tacagtgtgg 2400
aatttctgtt aaaatccaat ggatatcgct atgattaaat gacatccatt taccatttct 2460
gtatttaatg tatcatcagg acattaagat ttgttattct tgtaagattt ttgtttatta 2520
agtgtatttt agaagatttt gccaagatta aaatttgtgg tagccggcta gacatattgg 2580
tgtcgccatc ttggaatttc atcataatgt agcaatattt tttatgaaca ttacttatat 2640
attgaagtta atatgtatat atttaagtaa tttatatcat ttaattctta aaatgttaag 2700
ttaaaacgcc aagttgtact ttgaactctt tggtgcactc tgggtcatgt ccaaagtatg 2760
attatgttaa gtaatatcaa tataacatac ttaaaaggaa aatattttcg gtaaactgtg 2820
tgtaatacat agttcttgat aaccttttat tgaaatttta ttttaaaaac gttcgtaaat 2880
tccgacacaa cttcatacaa aagcagtagt tcgactcggt ccaaattggt caatatcatg 2940
aaaatgtcat ttgattctat tgaaatatgt ttgttttgtt taacctggaa aacattttaa 3000
acgttttaaa tcataattat cattttgtaa caaaatataa gtaaacaaag cggtgacagg 3060
cattatagca cacgtggtca agatggcggc cattttgatt tgtacaatct gttgtgtggt 3120
attgagtaat tgaatagggc cgcttataat tctttcttaa aaaagtaatg gcgcactgaa 3180
gtataagaaa gtgttgaaaa cattgagtac ttttgaaaca gtcagtggaa atcagtttcc 3240
aattcagctg ttgaactctc tgctttgttt gaacacactg tcttgtgatg cagctgttgc 3300
attatccaca gcaatgttac atagtcaact aatcaatggg ttttattgtc aaatctaaac 3360
aaggttcccc ctgatgttta tgatgaccat agtagttgta atttagttaa ttgcaaattt 3420
cttttaaaat tacagtatct agagtaataa aaacaaggag caacg 3465
<210> 2
<211> 38
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
cgcgggcccg ggatccacta tatgacggac tggacaac 38
<210> 3
<211> 40
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
ggcgaccggt ggatcccgtt gctccttgtt tttattactc 40
Claims (9)
1. An oyster EF-1 alpha promoter is characterized in that the sequence of the promoter is shown as SEQ ID NO. 1.
2. A recombinant expression vector comprising a nucleotide fragment having the sequence of SEQ ID NO. 1.
3. The method for constructing the recombinant expression vector of claim 2, which comprises the following steps:
1) designing a Pair of specific amplification primers of an EF-1 alpha gene upstream promoter of the crassostrea gigas according to a crassostrea gigas genome sequence, and adding plasmid homologous ends, wherein the sequences are shown as SEQ ID NO. 2 and SEQ ID NO. 3;
2) taking the genomic DNA of the crassostrea gigas as a template, carrying out PCR amplification, and recovering a product;
3) digesting the plasmid and recovering the product;
4) carrying out In-Fusion connection on the enzyme digestion linearized plasmid and the recovered PCR product In the step 2), introducing the connection product into escherichia coli competent cells, carrying out plate screening, and selecting monoclonal shake bacteria for culture;
5) extracting bacteria liquid plasmids, carrying out enzyme digestion, selecting plasmids which accord with expectation according to the enzyme digestion result, sequencing, and naming the plasmids with correct sequencing as pEGFP-CgEF-1 alpha, namely the recombinant expression vector.
4. The construction method according to claim 3, wherein the PCR system in step 2) is: 5x Phusion HF Buffer, 10. mu.l; 2.5mM dNTPs, 4. mu.l; upstream primer 10uM, 2.5. mu.l; downstream primer 10uM, 2.5. mu.l; template DNA 100 ng/. mu.l, 1. mu.l; phusion High-Fidelity DNA Polymerase 0.5. mu.l; 29.5. mu.l of ultrapure water; the amplification procedure was: pre-denaturation at 98 ℃ for 30 s; denaturation at 98 ℃ for 10s, annealing at 64 ℃ for 30s, extension at 72 ℃ for 1min for 20s, and 35 cycles; extension at 72 ℃ for 10 min.
5. The construction method according to claim 4, wherein the enzyme cutting system in steps 3) and 5) is as follows: 10x CutSmart Buffer 5 ul, plasmid DNA 150 ng/ul, 6 ul, BamHI enzyme 20U/ul, 0.5 ul, ultra pure water 37.5 ul; the reaction program was 37 ℃ for 2 h.
6. The method of claim 3, wherein the In-Fusion linker system In step 4) is: 5 XIn-Fusion HD Enzyme Premix 2. mu.l, linearized pEGFP-1 plasmid DNA 43 ng/. mu.l, 1.5. mu.l, recovered product 16 ng/. mu.l, 6.5. mu.l; the reaction program is 50 ℃ for 15 min.
7. The method of claim 3, wherein the plasmid pEGFP-1 is selected in step 1).
8. The use of the crassostrea gigas EF-1 α promoter of claim 1 in crassostrea gigas gene breeding.
9. The method for using the recombinant expression vector of claim 3, wherein green fluorescence, i.e., the EGFP gene expression, is observed in each cell type of Mulberry stage, blastocyst stage, gastral stage embryo, trochophore and D-shaped larva by continuous observation under a fluorescence microscope after the mixture of the recombinant expression vector and phenol red is introduced into fertilized eggs of Ostreidae by microinjection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910975861.4A CN110684769B (en) | 2019-10-15 | 2019-10-15 | Ostrea gigas EF-1 alpha promoter, recombinant vector and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910975861.4A CN110684769B (en) | 2019-10-15 | 2019-10-15 | Ostrea gigas EF-1 alpha promoter, recombinant vector and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110684769A CN110684769A (en) | 2020-01-14 |
CN110684769B true CN110684769B (en) | 2022-04-05 |
Family
ID=69112648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910975861.4A Active CN110684769B (en) | 2019-10-15 | 2019-10-15 | Ostrea gigas EF-1 alpha promoter, recombinant vector and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110684769B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114164232A (en) * | 2021-11-05 | 2022-03-11 | 汕头大学 | Method for gene editing of electrotransfection bivalve shellfish |
CN114703174B (en) * | 2022-04-12 | 2023-10-24 | 中国科学院海洋研究所 | CRISPR/Cas9 gene knockout method for rapidly obtaining genotype and phenotype mutation and application thereof |
CN114703231B (en) * | 2022-04-12 | 2023-10-24 | 中国科学院海洋研究所 | Electroporation gene editing method and application of crassostrea gigas beta-tubulin gene |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5969211A (en) * | 1996-04-19 | 1999-10-19 | Ther Regents Of The University Of California | Pantropic retroviral vectors for gene transfer in mollusks |
CN104861056A (en) * | 2015-06-16 | 2015-08-26 | 中国科学院海洋研究所 | Recombinant protein CgC1qDC-1 of pacific oyster complement molecule, as well as preparation and application of recombinant protein CgC1qDC-1 |
CN109385451A (en) * | 2018-11-07 | 2019-02-26 | 中国海洋大学 | One seed oyster CRISPR/Cas9 gene editing method |
-
2019
- 2019-10-15 CN CN201910975861.4A patent/CN110684769B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5969211A (en) * | 1996-04-19 | 1999-10-19 | Ther Regents Of The University Of California | Pantropic retroviral vectors for gene transfer in mollusks |
CN104861056A (en) * | 2015-06-16 | 2015-08-26 | 中国科学院海洋研究所 | Recombinant protein CgC1qDC-1 of pacific oyster complement molecule, as well as preparation and application of recombinant protein CgC1qDC-1 |
CN109385451A (en) * | 2018-11-07 | 2019-02-26 | 中国海洋大学 | One seed oyster CRISPR/Cas9 gene editing method |
Non-Patent Citations (2)
Title |
---|
Regulation of Hox orthologues in the oyster Crassostrea gigas evidences a functional role for promoter DNA methylation in an invertebrate;Saint-Carlier, Emma等;《FEBS LETTERS》;20150604;第589卷(第13期);第1459-1466页 * |
岩牡蛎和长牡蛎的线粒体DNA PCR-RFLP快速鉴定;刘凯凯等;《中国海洋大学学报(自然科学版)》;20181231;第48卷;第1-4页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110684769A (en) | 2020-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108441520B (en) | Gene conditional knockout method constructed by using CRISPR/Cas9 system | |
CN106916820B (en) | SgRNA and its application of porcine ROSA 26 gene can effectively be edited | |
CN108642055B (en) | sgRNA capable of effectively editing pig miR-17-92 gene cluster | |
CN110684769B (en) | Ostrea gigas EF-1 alpha promoter, recombinant vector and application thereof | |
CN108546716A (en) | A kind of genome edit methods | |
CN108130342A (en) | Plant Genome fixed point edit methods based on Cpf1 | |
CN110305896B (en) | Construction method of zebra fish kidney progenitor cell marker transgenic line | |
CN109266650B (en) | Inducible promoter, recombinant vector and transformant thereof, method for inducing gene expression and application of inducible promoter | |
CN106086031B (en) | Pig flesh chalone gene editing site and its application | |
CN110643636A (en) | Megalobrama amblycephala MSTNa & b gene knockout method and application | |
CN106754949B (en) | Pig flesh chalone gene editing site 864-883 and its application | |
WO2019014917A1 (en) | Gene editing system and method for editing plant genome by using same | |
CN111549070B (en) | Method for editing X chromosome multicopy gene to realize animal sex control | |
CN112831498A (en) | Method for site-directed mutagenesis or insertion of oyster genome mediated by ssODN | |
CN108949769B (en) | Cotton bollworm ecdysone regulatory factor E78-C gene cDNA and application thereof | |
CN113621610B (en) | SgRNA sequence for knocking out partial conserved region of pig HSPA6 gene and application thereof | |
CN114807138B (en) | Plant annular RNA over-expression vector, construction method and application thereof | |
CN114540421B (en) | Controllable editing method for silkworm MSG and PSG expression genes | |
CN109504680B (en) | Salt stress inducible promoter, primer, expression vector and application thereof | |
CN114891791B (en) | sgRNA of specific targeting canine Rosa26 gene and application thereof | |
CN113913468B (en) | Gene editing method for spider | |
CN110791503A (en) | Low-phosphorus inducible promoter and application thereof | |
CN114891786B (en) | Dog Rosa26 gene and application thereof | |
CN103642806B (en) | Based on isolation of promoter and the qualification of sheep hair follicle specific expression gene | |
CN116987694A (en) | Bidirectional promoter of medaka and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |